Be Ready to Dispense New ORAL Semaglutide for Weight Loss
February 2026
Patients are asking about Rx semaglutide tablets (Wegovy), the first ORAL GLP-1 agonist FDA-approved for obesity and overweight.
It’s the same med in injectable Wegovy for weight loss...or injectable Ozempic or oral Rybelsus for type 2 diabetes.
But oral Wegovy is taken DAILY...versus weekly with the injection.
Practical advice for a better career, with unlimited access to CE
Pharmacy Technician's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 120+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote